TP53 and metastatic neoplasm: In contrast, of the 15 cases that were TP53 wild type, 9 had metastatic disease at the time of sequencing or metastatic disease was identified at subsequent follow up; while 6 remained without evidence of metastatic disease on follow up (Table 3).